Brugada Syndrome Market – Global Overview and Forecast (2023-2029)

Brugada Syndrome Market size was valued at US$ 1.40 Bn. in 2022 and the total Brugada Syndrome revenue is expected to grow at 6.5% through 2022 to 2029, reaching nearly US$ 2.18 Bn.
Brugada Syndrome Market Overview:

Brugada syndrome is a disorder in which the heart's regular rhythm is interrupted sometimes resulting in chronic heart disease or failure. This condition can cause abnormal heart rhythms in the bottom chambers of the heart otherwise known as ventricles, a condition known as ventricular arrhythmia. If left untreated, abnormal heartbeats can lead to fainting (syncopal episode), seizures, breathing difficulties, and even death. These difficulties usually happen while the person is sleeping or relaxing. Preventive actions such as avoiding exacerbating drugs and lowering fever are among the Brugada syndrome remedies. An implanted cardioverter-defibrillator may be used as part of the therapy if necessary.